Long-term Follow-up Data from Pivotal Studies of Adjuvant Trastuzumab in Early Breast Cancer

Por Kristeleit, Hartmut, Parton, Marina, Beresford, Mark, Macpherson, Iain R., Sharma, Rajan, Lazarus, Loren, Kelleher, Muireann
Publicado no Target Oncol (2016)

The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients

Por Kelleher, Muireann T., Fruhwirth, Gilbert, Patel, Gargi, Ofo, Enyinnaya, Festy, Frederic, Barber, Paul R., Ameer-Beg, Simon M., Vojnovic, Borivoj, Gillett, Cheryl, Coolen, Anthony, Kéri, György, Ellis, Paul A., Ng, Tony
Publicado em 2009

HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status

Por Weitsman, Gregory, Barber, Paul R., Nguyen, Lan K., Lawler, Katherine, Patel, Gargi, Woodman, Natalie, Kelleher, Muireann T., Pinder, Sarah E., Rowley, Mark, Ellis, Paul A., Purushotham, Anand D., Coolen, Anthonius C., Kholodenko, Boris N., Vojnovic, Borivoj, Gillett, Cheryl, Ng, Tony
Publicado no Oncotarget (2016)

Imaging tumour heterogeneity of the consequences of a PKCα–substrate interaction in breast cancer patients

Por Weitsman, Gregory, Lawler, Katherine, Kelleher, Muireann T., Barrett, James E., Barber, Paul R., Shamil, Eamon, Festy, Frederic, Patel, Gargi, Fruhwirth, Gilbert O., Huang, Lufei, Tullis, Iain D.C., Woodman, Natalie, Ofo, Enyinnaya, Ameer-Beg, Simon M., Irshad, Sheeba, Condeelis, John, Gillett, Cheryl E., Ellis, Paul A., Vojnovic, Borivoj, Coolen, Anthony C.C., Ng, Tony
Publicado no Biochem Soc Trans (2014)